The Oncologist:Patient Conversation Must Include Clinical Trials
Sep 20, 2022, 02:00 PM
Dr. Shalaan Beg, VP of Oncology for Science 37, discusses his approach to reducing the time to trial activation at an NCI designated cancer center, how to ensure a diverse representation in clinical trials, and his opinion on decentralized and hybrid trials.